BridgeBio Pharma Share Holder Equity 2018-2024 | BBIO

BridgeBio Pharma share holder equity for the quarter ending December 31, 2024 was $-1.458B, a 8.54% increase year-over-year.

  • BridgeBio Pharma share holder equity for 2024 was $-1.458B, a 8.54% increase from 2023.
  • BridgeBio Pharma share holder equity for 2023 was $-1.343B, a 8.02% increase from 2022.
  • BridgeBio Pharma share holder equity for 2022 was $-1.243B, a 43.41% increase from 2021.
Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$15.5B
Dr Reddy's Laboratories (RDY)$11.4B
Bausch Health Cos (BHC)$1.9B
Supernus Pharmaceuticals (SUPN)$1.7B
Amphastar Pharmaceuticals (AMPH)$1.1B
Personalis (PSNL)$282M
Taysha Gene Therapies (TSHA)$254M
Assembly Biosciences (ASMB)$75M
Sol-Gel Technologies (SLGL)$15M
Evoke Pharma (EVOK)$3M
Teligent (TLGT)$0M